The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML. Stasik S, Eckardt JN, Rollig C, Baldus CD, et al. Br J Haematol 2025;206:1373-1379.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stasik S, Eckardt JN, Rollig C, Baldus CD, et al. The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML. Br J Haematol 2025;206:1373-1379.
PMID: 40041934